Personalis (PSNL) Cash from Financing Activities (2018 - 2026)
Personalis (PSNL) posted quarterly Cash from Financing Activities of $17.8 million for Q1 2026, down 11.24% year-over-year from $20.1 million in Q1 2025, and down 83.92% on a QoQ basis from $110.9 million in Q4 2025.
Personalis (PSNL) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Personalis (PSNL) has reported Cash from Financing Activities for 9 consecutive years, with $17.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 11.24% year-over-year to $17.8 million; the TTM figure through Mar 2026 stood at $128.1 million (down 4.15% YoY), while the FY2025 annual figure was $130.3 million, up 13.66% from the prior year.
- Cash from Financing Activities came in at $17.8 million for Q1 2026 at Personalis, down from $110.9 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $110.9 million in Q4 2025, with the low at -$420000.0 in Q2 2022.
- Average Cash from Financing Activities over 5 years is $18.3 million, with a median of $1.1 million recorded in 2024.
- Across the five-year window, Cash from Financing Activities soared 21426.21% in 2024 and plunged 121.57% in 2025, its largest moves.
- Year by year, Cash from Financing Activities stood at $511000.0 in 2022, then soared by 1820.94% to $9.8 million in 2023, then jumped by 405.31% to $49.6 million in 2024, then surged by 123.57% to $110.9 million in 2025, then plunged by 83.92% to $17.8 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $17.8 million, $110.9 million, and -$317000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 3.76 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -144.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Personalis | 1.44 Bn | 1.20 Bn | 281,000.00 | 17.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.83 Mn |
| Mar 31, 2026 | 17.83 Mn |
| Dec 31, 2025 | 110.90 Mn |
| Dec 31, 2025 | 110.90 Mn |
| Sep 30, 2025 | -317,000.00 |
| Sep 30, 2025 | -317,000.00 |
| Jun 30, 2025 | -327,000.00 |
| Jun 30, 2025 | -327,000.00 |
| Mar 31, 2025 | 20.09 Mn |
| Mar 31, 2025 | 20.09 Mn |
| Dec 31, 2024 | 49.60 Mn |
| Dec 31, 2024 | 49.60 Mn |
| Sep 30, 2024 | 62.43 Mn |
| Sep 30, 2024 | 62.43 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | 9.82 Mn |
| Dec 31, 2023 | 9.82 Mn |